| Date | Nonproprietary name | Detailed information on revisions of PRECAUTIONS (from MHLW) | Summary of investigation results (from PMDA) |
|---|---|---|---|
| January 13, 2026 | Idecabtagene vicleucel | PRECAUTIONS [43.3 KB] |
Summary of Investigation [113 KB] |
| Ciltacabtagene autoleucel | PRECAUTIONS [47 KB] |
Summary of Investigation [113 KB] |
|
| Tisagenlecleucel | PRECAUTIONS [43.3 KB] |
Summary of Investigation [113 KB] |
|
| Ciltacabtagene autoleucel | PRECAUTIONS [45.2 KB] |
Summary of Investigation [81.7 KB] |
|
| November 26, 2025 | Onasemnogene abeparvovec | PRECAUTIONS [46 KB] |
Summary of Investigation [55 KB] |
| August 28, 2025 | Delandistrogene moxeparvovec | PRECAUTIONS [39.3 KB] |
Summary of Investigation [103 KB] |
| May 20,2025 | Onasemnogene abeparvovec | PRECAUTIONS [13.5 KB] |
Summary of Investigation [136 KB] |